DE69033937T2 - Verfahren zur Herstellung von genetischen Vektoren zur Expression vom Nerven-Wachstumsfaktor in eukaryotischen Zellen - Google Patents

Verfahren zur Herstellung von genetischen Vektoren zur Expression vom Nerven-Wachstumsfaktor in eukaryotischen Zellen

Info

Publication number
DE69033937T2
DE69033937T2 DE69033937T DE69033937T DE69033937T2 DE 69033937 T2 DE69033937 T2 DE 69033937T2 DE 69033937 T DE69033937 T DE 69033937T DE 69033937 T DE69033937 T DE 69033937T DE 69033937 T2 DE69033937 T2 DE 69033937T2
Authority
DE
Germany
Prior art keywords
fragment
ngf
base pair
bamhi
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69033937T
Other languages
German (de)
English (en)
Other versions
DE69033937D1 (de
Inventor
Lanfranco Callegaro
Francesco Della Valle
Alessandro Negro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fidia Farmaceutici SpA
Original Assignee
Fidia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia SpA filed Critical Fidia SpA
Application granted granted Critical
Publication of DE69033937D1 publication Critical patent/DE69033937D1/de
Publication of DE69033937T2 publication Critical patent/DE69033937T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/48—Nerve growth factor [NGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Plant Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69033937T 1989-11-16 1990-11-16 Verfahren zur Herstellung von genetischen Vektoren zur Expression vom Nerven-Wachstumsfaktor in eukaryotischen Zellen Expired - Fee Related DE69033937T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT04856489A IT1238348B (it) 1989-11-16 1989-11-16 Processo per la preparazione di costrutti genetici per l'espressione del fattore di crescita nervoso in cellule eucariote.

Publications (2)

Publication Number Publication Date
DE69033937D1 DE69033937D1 (de) 2002-04-25
DE69033937T2 true DE69033937T2 (de) 2002-11-14

Family

ID=11267348

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69033937T Expired - Fee Related DE69033937T2 (de) 1989-11-16 1990-11-16 Verfahren zur Herstellung von genetischen Vektoren zur Expression vom Nerven-Wachstumsfaktor in eukaryotischen Zellen

Country Status (22)

Country Link
US (1) US5457034A (enExample)
EP (1) EP0432510B1 (enExample)
JP (2) JP3121611B2 (enExample)
KR (1) KR910009929A (enExample)
CN (1) CN1051934A (enExample)
AR (1) AR246983A1 (enExample)
AT (1) ATE214735T1 (enExample)
CA (1) CA2030108C (enExample)
DE (1) DE69033937T2 (enExample)
ES (1) ES2173856T3 (enExample)
FI (1) FI905691L (enExample)
HU (1) HUT61047A (enExample)
IE (1) IE904120A1 (enExample)
IL (1) IL96347A (enExample)
IT (1) IT1238348B (enExample)
NZ (1) NZ236058A (enExample)
PE (1) PE28191A1 (enExample)
PL (1) PL287811A1 (enExample)
PT (1) PT95911B (enExample)
TW (1) TW205069B (enExample)
YU (1) YU217890A (enExample)
ZA (1) ZA909122B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169762A (en) * 1983-03-03 1992-12-08 Genentech, Inc. Human nerve growth factor by recombinant technology
US6964947B1 (en) 1995-11-07 2005-11-15 Genentech, Inc. Stabilizing formulation for NGF
US6090781A (en) * 1996-11-06 2000-07-18 Genentech, Inc. Stabilizing formulation for NGF
AU1447600A (en) * 1998-10-22 2000-05-08 Thomas J. Gardella Bioactive peptides and peptide derivatives of parathyroid hormone (pth) and parathyroid hormone-related peptide (pthrp)
WO2001023521A2 (en) * 1999-09-29 2001-04-05 The General Hospital Corporation Polypeptide derivatives of parathyroid hormone (pth)
ES2316354T3 (es) 1999-09-29 2009-04-16 The General Hospital Corporation Derivados polipeptidos de la hormona paratiroidea (pth).
US6696238B2 (en) 2000-07-28 2004-02-24 Christopher J. Murphy Transplant media
US7572765B2 (en) * 2001-07-23 2009-08-11 The General Hospital Corporation Conformationally constrained parathyroid hormone (PTH) analogs
AU2003220380A1 (en) 2003-03-19 2004-11-19 Bristol-Myers Squibb Company CONFORMATIONALLY CONSTRAINED PARATHYROID HORMONES WITH Alpha-HELIX STABILIZERS
JP4871128B2 (ja) 2003-07-17 2012-02-08 ザ ジェネラル ホスピタル コーポレイション 高次構造的に制約された副甲状腺ホルモン（ｐｔｈ）アナログ
US20070207209A1 (en) * 2004-08-27 2007-09-06 Murphy Christopher J Trophic factor combinations for nervous system treatment
EP2054077A4 (en) * 2006-08-04 2010-10-13 Gen Hospital Corp POLYPEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH)
CN101260398B (zh) 2007-03-07 2013-06-05 舒泰神（北京）生物制药股份有限公司 神经生长因子基因定位改造动物及其制备方法和应用
BRPI0814962B8 (pt) 2007-08-01 2021-05-25 Chugai Pharmaceutical Co Ltd métodos in vitro para determinar se um composto candidato é um agonista de longa duração ou de curta duração de um receptor acoplado à proteína g, polipeptídeo, seu uso e composição farmacêutica
CN101927012B (zh) * 2009-06-26 2013-08-14 丽珠医药集团股份有限公司 神经生长因子的病毒灭活方法
US9492508B2 (en) 2010-05-13 2016-11-15 The General Hospital Corporation Parathyroid hormone analogs and uses thereof
CN102816766A (zh) * 2012-05-04 2012-12-12 沈阳医学院 蛇毒神经生长因子活性多肽的筛选方法
US20240018481A1 (en) * 2021-07-30 2024-01-18 Chengdu Unovel Biopharma Co., Ltd. Recombinant cho cell, construction method therefor, and detection system and method using same
CN115894705A (zh) * 2021-09-30 2023-04-04 三生国健药业（上海）股份有限公司 一种β-NGF融合蛋白、其制备方法及用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161152C (da) * 1983-03-03 1991-11-11 Genentech Inc Polypeptid med egenskaber som human beta-nervevaekstfaktor og fremgangsmaade til fremstilling deraf, dna-isolat omfattende en sekvens som koder for polypeptidet, replicerbar udtrykkelsesvektor for dna-sekvensen, rekombinant vaertscelle transformeret med vektoren, farmaceutisk praeparat indeholdende polypeptidet og fremg. der omfatter anvendelsen af polypeptidet til fremst. af et farmaceutisk praeparat
US4796580A (en) * 1987-09-11 1989-01-10 Allied-Signal Inc. Idle control valve for use with a throttle assembly of an internal combustion engine
JPH01211490A (ja) * 1988-02-19 1989-08-24 Tosoh Corp ヒト神経成長因子遺伝子セグメント
US5272063A (en) * 1988-11-22 1993-12-21 Syntex (U.S.A.) Inc. Process of making human nerve growth factor

Also Published As

Publication number Publication date
CN1051934A (zh) 1991-06-05
US5457034A (en) 1995-10-10
IE904120A1 (en) 1991-05-22
JPH03224490A (ja) 1991-10-03
EP0432510A1 (en) 1991-06-19
IT1238348B (it) 1993-07-13
CA2030108C (en) 1998-04-28
HUT61047A (en) 1992-11-30
ATE214735T1 (de) 2002-04-15
NZ236058A (en) 1993-04-28
IL96347A (en) 1997-11-20
ZA909122B (en) 1991-09-25
IL96347A0 (en) 1991-08-16
JP2001000194A (ja) 2001-01-09
HU907174D0 (en) 1991-05-28
PL287811A1 (en) 1991-12-02
PT95911B (pt) 1998-01-30
AU6655890A (en) 1991-05-23
JP3121611B2 (ja) 2001-01-09
AR246983A1 (es) 1994-10-31
FI905691A7 (fi) 1991-05-17
EP0432510B1 (en) 2002-03-20
PE28191A1 (es) 1991-10-28
DE69033937D1 (de) 2002-04-25
YU217890A (sh) 1993-05-28
PT95911A (pt) 1991-09-13
FI905691L (fi) 1991-05-17
KR910009929A (ko) 1991-06-28
IT8948564A0 (it) 1989-11-16
CA2030108A1 (en) 1991-05-17
TW205069B (enExample) 1993-05-01
FI905691A0 (fi) 1990-11-16
AU645998B2 (en) 1994-02-03
ES2173856T3 (es) 2002-11-01
IT8948564A1 (it) 1991-05-16

Similar Documents

Publication Publication Date Title
DE69033937T2 (de) Verfahren zur Herstellung von genetischen Vektoren zur Expression vom Nerven-Wachstumsfaktor in eukaryotischen Zellen
DE69034040T2 (de) Rekombinanter Abkömmling des menschlichen Faktors VIII
EP0538300B1 (de) O-glycosyliertes ifn-alpha
DE69233351T2 (de) Multimere der löslichen Formen der TNF-Rezeptoren, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE69230206T2 (de) Rekombinante derivate des menschlichen faktors viii
DE3887052T2 (de) Menschliche, Insulin ähnliche Wachstumfaktoren mit reduzierter Bindung zu Serumträgerproteinen und ihre Herstellung in Hefe.
DE3751406T2 (de) Herstellung und Verwendung von nicht-glycosiliertem IL-6.
DE69131449T2 (de) Verbesserte exotoxine aus pseudomonas mit geringer toxität bei tieren und hoher zelltötender aktivität
DE69017753T2 (de) Tumor-Nekrosefaktor-Bindungsprotein II, seine Reinigung und spezifische Antikörper.
DE60035871T2 (de) Expression und export von interferon-alpha proteinen als fc fusionsproteine
DE68916537T2 (de) Herstellung eines insulinähnlichen, wachstümsfaktor bindenden proteins.
DE69129697T2 (de) Aus mehreren domänen bestehende hämatopoese-stimulatoren
DE69028671T2 (de) Löslisches extrazellulares Fragment des menschlischen IFN-beta 2/IL-6-Rezeptors, seine Herstellung und diesen Fragment enthaltende pharmazeutische Mischung
DE69006100T2 (de) Fibronektin-Derivate.
DE69834556T2 (de) Modifizierte humane TNFalpha-Moleküle, DNA, welche für derartige veränderte TNFalpha-Moleküle kodieren und Impfstoffe, die derartige veränderte TNFalpha-Moleküle und DNA enthalten
DE3854328T2 (de) Nukleinsäuren und methoden für die synthese von neuen fusionspolypeptiden mit einem phospholipidankergebiet.
DE69329031T2 (de) Das dorsalgewebe beeinflussender faktor
DE69635675T2 (de) Verkürzter aus einer gliazelllinie gewonnener neurotropher faktor
DE69131426T2 (de) Neue wasserlösliche polypeptide mit hoher affinität für alpha- und beta- interferone
DE69331510T2 (de) TNF-Liganden
DE10235248A1 (de) Fusionsprotein mit verstärkter in vivo-Aktivität von Erythropoietin
DE69712124T2 (de) Hormones de croissance humaines mutantes et leur utilisation
DE69924009T2 (de) Methode zur verstärkung der biologischen aktivität von liganden
DE69331977T2 (de) Löslicher LDL-Rezeptor, seine Herstellung und Verwendung
DE69024693T2 (de) Gene, die ein Protein mit menschlicher MACIF-Aktivität kodieren, Expressionsvektoren mit diesen Genen, Transformantenzellen und Proteine mit menschlicher MACIF-Aktivität

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: FIDIA FARMACEUTICI S.P.A., ABANO TERME, PADUA/PADO

8339 Ceased/non-payment of the annual fee